Wall Street analyst estimates for INVO Fertility, Inc. (IVF): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-23 | $-0.65 | ||
| 2026-08-14 | $0.35 | $-0.70 | +150.0% |
| 2026-06-22 | $-3.38 | $-2.75 | -22.9% |
| 2026-05-06 | $-2.75 | $-2.75 | +0.0% |
| 2025-11-17 | $-30.80 | $-57.60 | +46.5% |
| 2025-08-14 | $-3.18 | $-0.72 | -341.7% |
| 2025-05-20 | $-15.04 | $-0.72 | -1988.5% |
| 2025-04-30 | $-10.85 | $-4.20 | -158.3% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50901 | $282145 | $494375 | $1.5M | $1.0M | $4.2M | $822196 | $3.0M | $6.5M | $6.8M |
| Cost of Revenue | $15094 | $51954 | $90367 | $139670 | $88760 | $145052 | $850770 | $1.9M | $3.7M | $4.3M |
| Gross Profit | $35807 | $230191 | $404008 | $1.3M | $948526 | $4.0M | -$28574 | $1.1M | $2.9M | $2.5M |
| Research & Development | 0 | 0 | 0 | 0 | $398426 | $216430 | $544043 | $165945 | $489660 | 0 |
| Selling, General & Admin | $2.1M | $870612 | $3.0M | $3.1M | $6.1M | $9.0M | $10.0M | $7.5M | $9.1M | $7.7M |
| Operating Expenses | $2.1M | $870612 | $3.0M | $3.1M | $6.5M | $9.2M | $10.6M | $7.9M | $11.0M | $8.4M |
| Operating Income | -$2.1M | -$640421 | -$2.6M | -$1.8M | -$5.5M | -$5.2M | -$10.6M | -$6.8M | -$8.1M | -$5.8M |
| EBITDA | -$2.1M | -$678480 | -$2.6M | -$1.8M | -$5.5M | -$5.2M | -$10.8M | -$6.9M | -$7.1M | -$3.5M |
| Interest Expense | $13838 | $20873 | $442031 | $379019 | $2.8M | $1.3M | $59445 | $925909 | $1.1M | $1.3M |
| Pre-tax Income | -$2.1M | -$702163 | -$3.1M | -$2.2M | -$8.3M | -$6.7M | -$10.9M | -$8.0M | -$9.1M | -$5.5M |
| Income Tax | 0 | 0 | 0 | $433 | $36 | $4764 | $2872 | $27786 | -$22913 | -$150371 |
| Net Income | -$2.1M | -$702163 | -$3.1M | -$2.2M | -$8.3M | -$6.7M | -$10.9M | -$8.0M | -$9.1M | -$23.3M |
| EPS | $-18432.00 | $-4580.35 | $-19243.00 | $-12856.00 | $-43791.00 | $-18026.00 | $-25877.00 | $-8084.16 | $-3178.43 | $-66.11 |
| EPS (Diluted) | $-18432.00 | $-4580.35 | $-19243.00 | $-12856.00 | $-43791.00 | $-18026.00 | $-25877.00 | $-8084.16 | $-3178.43 | $-66.11 |
| Shares Outstanding (Diluted) | $151 | $153 | $160 | $169 | $191 | $369 | $421 | $994 | $2514 | $117083 |
Price
| Price | $0.93 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AVGR · AXDX · CMAX · CUTR · NBSE · ONCSQ · ONCT
Explore sector: Healthcare · Medical - Devices
More sections of IVF: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks